Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma

被引:0
作者
Jinyuan Shi
Pu Wu
Lei Sheng
Wei Sun
Hao Zhang
机构
[1] The First Hospital of China Medical University,Department of Thyroid Surgery
[2] Qilu Hospital of Shandong University,Department of Thyroid Surgery, General Surgery
来源
Cancer Cell International | / 21卷
关键词
Papillary thyroid carcinoma; Ferroptosis genes; Gene signature; Prognosis; TCGA;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 486 条
  • [1] James BC(2018)An update in international trends in incidence rates of thyroid cancer, 1973–2007 Cancer Causes Control 29 465-473
  • [2] Mitchell JM(2013)Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors J Cancer Epidemiol 2013 965212-653
  • [3] Jeon HD(2016)The changing incidence of thyroid cancer Nat Rev Endocrinol 12 646-622
  • [4] Vasilottos N(2018)Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients World J Surg 42 615-1013
  • [5] Grogan RH(2018)Co-existence of BRAF(V600E) and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis Cancer Manag Res 10 1005-285
  • [6] Aschebrook-Kilfoy B(2017)Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease Cell 171 273-1072
  • [7] Pellegriti G(2012)Ferroptosis: an iron-dependent form of nonapoptotic cell death Cell 149 1060-379
  • [8] Frasca F(2016)Ferroptosis: process and function Cell Death Differ 23 369-1604
  • [9] Regalbuto C(2019)Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond Endocr Rev 40 1573-616
  • [10] Squatrito S(2018)Molecular therapies and precision medicine for hepatocellular carcinoma Nat Rev Clin Oncol 15 599-134